Log in or Sign up for Free to view tailored content for your specialty!
Pediatric ID News
NIH picks Kathleen M. Neuzil, MD, MPH, to lead Fogarty International Center
The NIH has chosen vaccine researcher Kathleen M. Neuzil, MD, MPH, to be the new director of the Fogarty International Center.
CDC data show TB case counts increased in US since COVID-19 pandemic
Although the United States has one of the lowest tuberculosis incidence rates in the world, TB cases increased in the U.S. in 2023 among nearly all demographics, data from an MMWR report showed.
Log in or Sign up for Free to view tailored content for your specialty!
Puerto Rico declares public health emergency after spike in dengue cases
Puerto Rico has declared a public health emergency following a spike in cases of dengue.
FDA authorizes emergency use of pemivibart for COVID-19 prevention
The FDA authorized emergency use of pemivibart for pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg.
Q&A: What to know about the new pediatric guidance for COVID-19
A task force supported by the Pediatric Infectious Diseases Society recently published the first guidance for the prevention and treatment of COVID-19 in children in the vaccine era.
Pooled saliva testing catches asymptomatic cases of congenital CMV
Universal screening using pooled saliva PCR testing helped identify dozens of newborns with congenital cytomegalovirus at two hospitals in Israel, more than half of whom were asymptomatic, according to findings published in Nature Medicine.
MIS-C cases increased last fall, study finds
Cases of multisystem inflammatory syndrome in children increased by nearly two-thirds last fall, aligning with an increase in COVID-19 activity, according to a study published in MMWR.
Personalized care could help plan safe return to work, school from flu, RSV
Personalized care could help patients and providers plan safe returns to work or school from respiratory illnesses, according to a research review.
Four children achieve treatment-free HIV remission for 1 year
DENVER — Four children born with HIV who initiated ART within 48 hours of delivery later remained in treatment-free remission for over a year after ART was paused, researchers reported.
Nirsevimab highly effective at preventing RSV hospitalization in infants, report shows
The monoclonal antibody nirsevimab is 90% effective at preventing respiratory syncytial virus hospitalization in infants, according to research published in MMWR.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read